• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Logistical barriers may impact access to contraceptive use amongst females with opioid use disorder

byNancy LuandAvneesh Bhangu
December 8, 2021
in Obstetrics, Wellness
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Females with opioid use disorder have many logistical barriers to accessing contraceptives, including homelessness and lack of transportation.

2. This study found accessing contraceptives at syringe exchange programs may be one avenue to provide contraceptive care in this population.

Evidence Rating Level: 3 (Average)

Compared to the general United States population, women who have opioid use disorder (OUD) are far more likely to have unintended pregnancies. Almost 90% of pregnancies of women with OUD are unintended. Prior research has suggested that these individuals are much less likely to use contraceptive methods, such as condoms. However, prior research has not explored the reasons for such disparities in contraceptive methods.

This study used a sample recruited from a volunteer-run non-profit syringe exchange program (SEP) in Santa Ana, California, United States of America between March and December 2019. Participants were included if they were aged 18-45, used injection drugs, spoke English or Spanish, and did not intend to become pregnant (n=14). Interviews were conducted with the participants. This qualitative study assessed outcomes related to patient experiences with contraception, past experiences with health care providers, and ability to obtain contraceptives.

From the interviews, most participants noted that contraception was not a main priority during periods of substance abuse. Participants also noted logistical barriers, including homelessness, lack of transportation, and lack of insurance as a financial barrier to contraception. Several participants additionally believed they could not become pregnant while using substances due to the lack of menstrual periods. Participants did note that they would probably use contraceptives if they were more readily accessible and incorporated as another service at syringe exchange programs. This study did have several limitations, notably its small sample size, homelessness as a potential confounding variable, and social desirability bias. Despite these limitations, this study furthered our understanding of barriers to contraceptive use in this population.

RELATED REPORTS

Evidence gap for acute pain outcomes in opioid use disorder

#VisualAbstract: Methadone is a Better Treatment for Opioid Use Disorder than Buprenorphine/Naloxone

#VisualAbstract: The Positive Health Programme (PHP) Quickened Recovery From Postnatal Depression in British South

Click to read the study in Journal of Addiction Medicine

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: addictionscontraceptivehomelessopioid use disorderOUDwellnesswomen
Previous Post

COVID-19 shutdown may have decreased gambling rates in Australia

Next Post

Geriatric assessment and management may reduce adverse events in older cancer patients

RelatedReports

Parental nonmedical prescription opioid use linked to adolescent use
Pharma

Evidence gap for acute pain outcomes in opioid use disorder

March 24, 2025
#VisualAbstract: Methadone is a Better Treatment for Opioid Use Disorder than Buprenorphine/Naloxone
StudyGraphics

#VisualAbstract: Methadone is a Better Treatment for Opioid Use Disorder than Buprenorphine/Naloxone

November 4, 2024
#VisualAbstract: The Positive Health Programme (PHP) Quickened Recovery From Postnatal Depression in British South
StudyGraphics

#VisualAbstract: The Positive Health Programme (PHP) Quickened Recovery From Postnatal Depression in British South

November 1, 2024
#VisualAbstract: Twice-Yearly Lenacapavir Prevented HIV Infections in Cisgender Young Girls and Adolescent Women
StudyGraphics

#VisualAbstract: Twice-Yearly Lenacapavir Prevented HIV Infections in Cisgender Young Girls and Adolescent Women

August 6, 2024
Next Post

Geriatric assessment and management may reduce adverse events in older cancer patients

Classics Series, Landmark Trials in Medicine

The CLOT trial: Dalteparin versus warfarin [Classics Series]

#VisualAbstract: Higher proportions time spent in physical activity decreased all-cause mortality

#VisualAbstract: Higher proportions time spent in physical activity decreased all-cause mortality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss
  • Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
  • 2 Minute Medicine Rewind June 23, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.